News
Feasibility study evaluates potential of digital health platform to help patients manage prostate cancer symptoms
A collaboration between Health Innovation Oxford & Thames Valley (HIOTV), Treatment Technology Insights (TTI) and Bayer is focussing on a digital platform and application to enable self-supported management for patients with prostate cancer.
Wave Health Named a 2024 ASCO® Breakthrough Abstract Award Winner
Treatment Technologies & Insights (TTI), a digital health insights and real-world data company and developer of the #1 rated ePRO app for Oncology, Wave Health, announced today it has been named a 2024 ASCO® Breakthrough Abstract Award winner in recognition of their 8-clinic PRO-WAVE1 study conducted in Spain.
Novel Study to Assess Wave Health for Stem Cell Transplant Patients Delivers Promising Results and Valuable Real-World Data
Interim results of a joint feasibility study conducted by TTI and the Wilmot Cancer Institute, involving the use of Wave Health, were selected for oral abstract presentation at the 2024 Oncology Nursing Society (ONS) Congress in Washington, D.C.
Patient Risk Management Platform, Wave Health, Delivers Rare 93% Patient Compliance and 98% HCP Perceived Usefulness
Presented at the 2024 ASCO Genitourinary Cancers Symposium, PRO-WAVE1 Research Results Showcase Opportunity to Operationalize the Patient-Provider Connection to Better Manage Cancer Care
New Data from Immunotherapy Study at Fred Hutchinson Accepted for Two Abstracts at 2023 ASCO
The Wave Health digital health platform, used to collect patient symptom and quality of life information in an innovative research study, comprises two abstracts accepted to the 2023 ASCO Annual Meeting.
Wave Health featured in NCODA professional student publication, Inspire
Inspire is the official publication of the NCODA Professional Student Organization. It engages young healthcare professionals with the latest news and insights in oncology pharmacy. Check out the latest issue of Inspire to read about how Wave Health is improving patient care!
Wave Health CEO & Founder Matt Lashey Featured on Entrepreneur Rx Podcast
This past week, CEO of TTI and creator of Wave Health, Matt Lashey, was featured on Entrepreneur Rx Podcast hosted by John Shufeldt, MD. Check out the interview here!
Wave Health Rated a Leading ePRO Platform for Oncology in 2022 Systematic Review
Recently, researchers at the University of Manchester and the Christie NHS Foundation Trust in the UK performed a systematic review of patient-facing cancer apps, in which Wave Health’s technology was validated as one of the leading ePRO platforms for oncology.
Wave Health Featured on Newsmax
The story of Ric Grenell and his cancer battle, which led to the creation of Wave App, was Featured on Newsmax TV’s morning news show, Wake Up America.
Wave App Rated #1 mHealth App By Cedars-Sinai Medical Center
A systemic review out of Cedars-Sinai Medical Center (CSMC) rated Wave as the #1 highest quality mHealth application to track patient-reported outcomes (PROs) for oncology patients.
Treatment Technologies & Insights, Inc (TTI) Launches Free New Health App
Wave App is now available for FREE on all mobile iPhone and Android platforms, as well as some wearable devices and tablets, for people with chronic illness or conditions to take control of their health and manage daily treatment.